Tivantinib and Topotecan Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors

NCT01654965 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

NIH

Sponsor class

Conditions

Adult Solid Neoplasm

Interventions

OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Pegfilgrastim
OTHER: Pharmacological Study
DRUG: Tivantinib
DRUG: Topotecan Hydrochloride

Sponsor

National Cancer Institute (NCI)